1,815
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Association between hypertensive medication during pregnancy and risk of several maternal and neonatal outcomes in women with chronic hypertension: a population-based study

, , &
Pages 637-645 | Received 02 Jul 2021, Accepted 17 Mar 2022, Published online: 06 May 2022

References

  • Borghi C, Ferri C, Sechi L. Italian society of hypertension. Clinical management of hypertension in pregnancy. Practical recommendations from the Italian Society of Hypertension (SIIA). High Blood Press Cardiovasc Prev. 2013 Sep;20(3):249. [corrected] [published correction appears in High Blood Press Cardiovasc Prev. 2013 Sep;20(3):249].
  • Nzelu D, Dumitrascu-Biris D, Hunt KF, et al. Pregnancy outcomes in women with previous gestational hypertension: a cohort study to guide counselling and management. Pregnancy Hypertens. 2018;12:194–200.
  • Al Khaja KA, Sequeira RP, Alkhaja AK, et al. Drug treatment of hypertension in pregnancy: a critical review of adult guideline recommendations. J Hypertens. 2014;32(3):454–463.
  • Hitti J, Sienas L, Walker S, et al. Contribution of hypertension to severe maternal morbidity. Am J Obstet Gynecol. 2018;219:405.e1–7.
  • Bortolotto MR, Francisco RPV, Zugaib M. Resistant hypertension in pregnancy: how to manage? Curr Hypertens Rep. 2018;20(8):63.
  • Lodi E, Carollo A, Martinotti V, et al. Hypertension and pharmacological therapy in women. High Blood Press Cardiovasc Prev. 2018;25(2018):147–150.
  • Magee LA, Pels A, Helewa M, et al. Canadian Hypertensive Disorders of Pregnancy (HDP) working group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens. 2014;4(2):105–145.
  • Macdonald-Wallis C, Lawlor DA, Fraser A, et al. Blood pressure change in normotensive, gestational hypertensive, preeclamptic, and essential hypertensive pregnancies. Hypertension. 2012;59(6):1241–1248.
  • Allen VM, Joseph K, Murphy KE, et al. The effect of hypertensive disorders in pregnancy on small for gestational age and stillbirth: a population based study. BMC Pregnancy Childbirth. 2004;4:17.
  • Duley L, Henderson-Smart DJ, Meher S. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2006;3:CD001449. DOI:10.1002/14651858.CD001449.pub2
  • Seely EW, Ecker J. Chronic hypertension in pregnancy. Circulation. 2014;129(11):1254–1261.
  • Macdonald-Wallis C, Tilling K, Fraser A, et al. Associations of blood pressure change in pregnancy with fetal growth and gestational age at delivery: findings from a prospective cohort. Hypertension. 2014;64(1):36–44.
  • Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension. 2008;51(4):960–969.
  • Cantarutti A, Franchi M, Rea F, et al. Use of nimesulide during early pregnancy and the risk of congenital malformations: a Population-based study from Italy. Adv Ther. 2018;35:981–992.
  • Cantarutti A, Merlino L, Giaquinto C, et al. Use of antidepressant medication in pregnancy and adverse neonatal outcomes: a population-based investigation. Pharmacoepidemiol Drug Saf. 2017;26:1100–1108.
  • Cantarutti A, Merlino L, Monzani E, et al. Is the risk of preterm birth and low birth weight affected by the use of antidepressant agents during pregnancy? A population-based investigation. PLoS One. 2016;11:e0168115.
  • Scott G, Gillon TE, Pels A, et al. Guidelines-similarities and dissimilarities: a systematic review of international clinical practice guidelines for pregnancy hypertension. Am J Obstet Gynecol. 2020;226(2S):S0002-9378(20)30846–2.
  • Magee LA, von Dadelszen P. State-of-the-art diagnosis and treatment of hypertension in pregnancy. Mayo Clin Proc. 2018;93(11):1664‐77.
  • Casey BM, McIntire DD, Leveno KJ. The continuing value of the Apgar score for the assessment of newborn infants. N Engl J Med. 2001;344:467–471.
  • Valero de Bernabé J, Soriano T, Albaladejo R, et al. Risk factor for low birth weight: a review. Eur J Obstet Gynecol. 2004;116:3–15.
  • Lawn JE, Gravett MG, Nunes TM, et al. Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data. BMC Pregnancy Childbirth. 2010;10:S1.
  • Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083–3107.
  • Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661–3679.
  • Desai RJ, Rothman KJ, Bateman BT, et al. A propensity‐score‐based fine stratification approach for confounding adjustment when exposure is infrequent. Epidemiology. 2017;28(2):249‐57.
  • Xu X, Wang Y, Xu H, et al. Association between proteinuria and maternal and neonatal outcomes in pre-eclampsia pregnancy: a retrospective observational study. J Int Med Res. 2020;48(4):300060520908114.
  • Tesfalul M, Sperling J, Blat C, et al. Adverse perinatal outcomes associated with elevated blood pressure and stage 1 hypertension. AJOG. 2020;1(Supplement):S92–3.
  • Bramham K, Parnell B, Nelson-Piercy C, et al. Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ. 2014;348:g2301.
  • Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15:565–574. discussion 575-577.
  • Schneeweiss S. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf. 2006;15:291–303.
  • Sibai BM, Mabie WC, Shamsa F, et al. A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy. Am J Obstet Gynecol. 1990;162(4):960–966.
  • Rezk M, Ellakwa H, Gamal A, et al. Maternal and fetal morbidity following discontinuation of antihypertensive drugs in mild to moderate chronic hypertension: a 4-year observational study. Pregnancy Hypertens. 2016;6(4):291–294.
  • Abalos E, Duley L, Steyn DW, et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2007;1:CD002252.
  • Magee LA, von Dadelszen P, Singer J, et al. CHIPS Study Group. The CHIPS randomized controlled trial (Control of Hypertension in Pregnancy Study): is severe hypertension just an elevated blood pressure? Hypertension. 2016;68(5):1153–1159.
  • Von Dadelszen P, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated meta regression analysis. J Obstet Gynaecol Can. 2002;24(12):941–945.
  • American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 125: chronic hypertension in pregnancy. Obstet Gynecol. 2012;119:396–407.
  • Su CY, Lin HC, Cheng HC, et al. Pregnancy outcomes of anti-hypertensives for women with chronic hypertension: a population-based study. PloS One. 2013;8:e53844.
  • Hypertension in pregnancy. Report of the American College of obstetricians and gynecologists’ task force on hypertension in pregnancy. American College of Obstetricians and Gynecologists. Task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–1131.
  • Tsakiridis I, Giouleka S, Arvanitaki A, et al. Chronic hypertension in pregnancy: synthesis of influential guidelines. J Perinat Med. 2021;49(7):859–872.
  • Abalos E, Duley L, Steyn D, et al. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2018;10:CD002252.
  • National Institute for Health and Care Excellence (UK). Hypertension in pregnancy: diagnosis and management. NICE guideline [NG133]. London: NICE. cited 2019 Jun 25. https://www.nice.org.uk/guidance/ng133] (ultimo accesso 27/07/2020
  • Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol. 2002 Aug;100(2):369–377.